Saratoga Investment Corp (SAR)
(Delayed Data from NYSE)
$24.09 USD
+0.27 (1.13%)
Updated Oct 14, 2024 04:00 PM ET
After-Market: $24.09 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Price, Consensus and EPS Surprise
SAR 24.09 +0.27(1.13%)
Will SAR be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for SAR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SAR
Saratoga Investment (SAR) Q2 Earnings and Revenues Top Estimates
Saratoga Investment (SAR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
SAR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Saratoga Investment (SAR) Surpasses Q1 Earnings and Revenue Estimates
What Makes Saratoga Investment (SAR) a New Buy Stock
Saratoga Investment (SAR) Lags Q4 Earnings Estimates
Other News for SAR
A Game Plan For BDC Investors Before The Earnings Season
Saratoga Investment price target raised by $1.50 at Compass Point, here's why
Maxim Group Keeps Their Buy Rating on Saratoga Investment (SAR)
Sareum Holdings Secures Funds for Phase 2 Trials
Oppenheimer Sticks to Its Hold Rating for Saratoga Investment (SAR)